Calculating The Fair Value Of Abcam plc (LON:ABC)
Does the November share price for Abcam plc ( LON:ABC ) reflect what it's really worth? Today, we will estimate the...
Has the U.K. Biotech Industry valuation changed over the past few years?
|Sun, 28 Nov 2021||UK£11.2b||UK£1.1b||-UK£123,066,197.00||63.1x|
|Tue, 26 Oct 2021||UK£12.4b||UK£1.1b||-UK£148,329,496.00||70.4x|
|Thu, 23 Sep 2021||UK£12.5b||UK£1.1b||-UK£143,618,678.00||54.1x|
|Sat, 21 Aug 2021||UK£12.4b||UK£1.0b||-UK£172,541,949.91||31.5x|
|Sat, 05 Jun 2021||UK£11.4b||UK£1.0b||-UK£166,338,934.52||30.7x|
|Tue, 09 Mar 2021||UK£11.5b||UK£1.0b||-UK£144,713,708.81||31.9x|
|Mon, 30 Nov 2020||UK£8.8b||UK£985.1m||-UK£119,804,987.81||60.8x|
|Thu, 03 Sep 2020||UK£8.2b||UK£992.8m||-UK£138,646,257.45||53.8x|
|Sun, 07 Jun 2020||UK£8.0b||UK£985.7m||-UK£114,704,522.81||57x|
|Sat, 29 Feb 2020||UK£6.0b||UK£946.5m||-UK£54,517,543.44||52.8x|
|Tue, 03 Dec 2019||UK£6.4b||UK£925.4m||-UK£84,370,311.30||62x|
|Fri, 06 Sep 2019||UK£5.4b||UK£898.9m||-UK£95,371,524.01||52.7x|
|Mon, 10 Jun 2019||UK£6.1b||UK£884.5m||-UK£97,895,948.36||56.9x|
|Sun, 03 Mar 2019||UK£5.5b||UK£873.1m||-UK£123,682,236.40||45.7x|
|Wed, 05 Dec 2018||UK£5.3b||UK£866.3m||-UK£98,066,918.16||60.3x|
Current Industry PE: Investors are more optimistic on the industry, considering it's trading at a PE ratio of 63.1x which is higher than its 3-year average PE of 50.1x. It appears they are confident that earnings will grow faster in the future than they have historically.
Past Earnings Growth: The earnings for companies in the Biotechs industry have deteriorated over the last three years, while revenues for these companies have grown 7.8% per year. This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Which industries have driven the changes within the U.K. Biotech industry?
Industry PE: Investors are most optimistic about the Biotech industry which is trading above its 3-year average PE ratio of 50.1x. However analysts are expecting annual earnings growth of 19%, which is lower than the prior year's growth of 32% per year. So the market might believe that analysts are underestimating future growth.
Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 19% over the next 5 years. However this is lower than its past earnings growth rate of 32% per year.
Which companies have driven the market over the last 7 days?
Faron Pharmaceuticals Oy